Drug Type Small molecule drug |
Synonyms VP 004, VP004 |
Target |
Action inhibitors |
Mechanism PKC inhibitors(Protein kinase C inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Lymphoid Leukemia | Preclinical | United Kingdom | 08 Oct 2023 |